Madrigal Pharmaceuticals
MDGL57
$276.34arrow_drop_up0.80%$2.21
High Growth
MDGL57
$276.34
arrow_drop_up0.80%| Key Stats | |
|---|---|
| Open | $278.72 |
| Prev. Close | $274.12 |
| EPS | -25.03 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 276.34 | 278.72 |
| 52 Week Range | 119.76 | 368.73 |
| Ratios | |
|---|---|
| Revenue | - |
| EBITDA Margin % | - |
| EPS | -25.03 |
| Fundamentals | |
|---|---|
| Gross Profit | - |
| Payout Ratio | - |
| Industry average yield | 2.97% |
| Last Dividend pay date | Jul 25, 2016 |
| Dividend per share | - |
| Dividend yield forecast | - |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
MDGL-
US Healthcare Sector-
US Market-
warning
MDGL / Market
MDGL lose to the US Market which returned 1.13% over the last twenty four hours.warning
MDGL / Healthcare Sector
MDGL lose to the US Healthcare sector which returned 2.80% over the last twenty four hours.Madrigal Pharmaceuticals (MDGL) Statistics
Keep an eye on Madrigal Pharmaceuticals
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
How has Madrigal Pharmaceuticals (MDGL) stock's performance compared to its sector and the market over the past year?
Over the past year, Madrigal Pharmaceuticals (MDGL) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 23.18%, Madrigal Pharmaceuticals has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 46.32%, it has fallen short of the market average. This comparison highlights Madrigal Pharmaceuticals 's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of Madrigal Pharmaceuticals (MDGL) stock?
The PE ratio for Madrigal Pharmaceuticals (MDGL) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help
What is the EPS of Madrigal Pharmaceuticals (MDGL) stock?
The Earnings Per Share (EPS) for Madrigal Pharmaceuticals (MDGL), calculated on a diluted basis, is -$25.03. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of Madrigal Pharmaceuticals (MDGL) stock?
The operating margin for Madrigal Pharmaceuticals (MDGL) is -187.06%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of Madrigal Pharmaceuticals (MDGL) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Madrigal Pharmaceuticals (MDGL) is -$547.18M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does Madrigal Pharmaceuticals (MDGL) have?
Madrigal Pharmaceuticals (MDGL) has a total debt of $119.14M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$113.54M.